Literature DB >> 12923405

Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats.

Teresa M Camp1, Lane M Smiley, Melvin R Hayden, Suresh C Tyagi.   

Abstract

BACKGROUND: Renal interstitial fibrosis and thickening of the glomerular basement membrane are associated with hypertension. However, the mechanism of matrix accumulation is unclear. Spontaneously hypertensive rats (SHR) develop hypertension at between 2 and 6 weeks of age.
METHODS: To test the hypothesis that increased matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) contribute to the pathomechanisms of hypertensive nephropathy, the cortex and medulla of male SHR at 2 and 6 weeks were analyzed for MMP-2, MMP-7, and MMP-9 by gelatin and elastin gel zymography. The levels of TIMP-4 were measured by western blot analysis. The bands in blots were scanned and normalized with actin. To localize MMP-2 and TIMP-4 in situ, immuno-labeling was performed. To determine proteinuresis, urinary protein was measured by Bio-Rad dye binding assay. The mean arterial pressure (mmHg) was measured in Inactin-anesthetized rats by a PE-50 catheter in the femoral artery. Age-sex matched normotensive Wistar rats (NWR) were used as controls and grouped: (1). SHR, 2 weeks; (2). SHR, 6 weeks; (3). NWR, 2 weeks; and (4). NWR, 6 weeks (n = 6 in each group).
RESULTS: Levels of cortex MMP-2 and MMP-9 were increased in 6 week SHR as compared with NWR. In the medulla, MMP-9 and MMP-7 were increased, but there was no change in MMP-2. The levels of cortex TIMP-4 tended to increase but insignificantly. In contrast, there were significant increases in the levels of TIMP-4 in the medulla of 6 week SHR as compared with 2 week SHR or NWR. In addition, there were substantial elastinolytic activity in the cortex of 6 week SHR. The in situ labeling suggested no TIMP-4 in the glomeruli. There was substantial TIMP-4 in the epithelial layer of tubules. The levels of fibrotic collagen were significantly higher in both the glomeruli and tubular interstitium. Urinary protein excretion was increased significantly in 6 week SHR when compared with other groups. The mean arterial pressure was 1.6-fold higher in 6 week SHR than in controls.
CONCLUSION: These results suggest that increased MMP-2 and MMP-9 activity contributes to glomerular injury and hypertensive remodeling. The increased levels of TIMP-4 in the medulla may inhibit the collagenolytic activity of MMP but is unable to inhibit the elastinolytic activity. An important role of MMP-2, MMP-9, and TIMP-4 in hypertensive remodeling of the cortex and medulla in the SHR is demonstrated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923405     DOI: 10.1097/00004872-200309000-00022

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  25 in total

1.  Temporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.

Authors:  Jan Michael Williams; Marilyn Burke; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

2.  Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

Authors:  Jan M Williams; Jin Zhang; Paula North; Steven Lacy; Michael Yakes; Annette Dahly-Vernon; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

3.  Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction.

Authors:  Edward D Tran; Frank A DeLano; Geert W Schmid-Schönbein
Journal:  J Vasc Res       Date:  2010-02-06       Impact factor: 1.934

4.  Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat.

Authors:  Kwan-I Sharon Wu; Geert W Schmid-Schönbein
Journal:  Hypertension       Date:  2011-01-10       Impact factor: 10.190

Review 5.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

6.  Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice.

Authors:  Umadevi Subramanian; Prerna Kumar; Indra Mani; David Chen; Isaac Kessler; Ramu Periyasamy; Giri Raghavaraju; Kailash N Pandey
Journal:  Physiol Genomics       Date:  2016-05-06       Impact factor: 3.107

7.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

8.  Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.

Authors:  Utpal Sen; Walter E Rodriguez; Neetu Tyagi; Munish Kumar; Soumi Kundu; Suresh C Tyagi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-09       Impact factor: 4.310

9.  Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats.

Authors:  Karen M Moritz; Marc Q Mazzuca; Andrew L Siebel; Amy Mibus; Debbie Arena; Marianne Tare; Julie A Owens; Mary E Wlodek
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

Review 10.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.